Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.45 |
| ▸ | RXRA | P19793 | 1/20 | 0.45 |
| ▸ | RXRB | P28702 | 1/20 | 0.45 |
| ▸ | RXRG | P48443 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | NR1H4 | Q96RI1 | 3/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.37 |
| ▸ | PPARD | Q03181 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1404313 | 0.89 | FOLH1 (0.56) | FOLH1FFAR4FFAR1 | |
| SCHEMBL25797889 | 0.87 | FOLH1 (0.49) | FOLH1FFAR4RXRARXRBRXRG | |
| SCHEMBL25741233 | 0.85 | FOLH1 (0.52) | FOLH1FFAR4CYP2D6FFAR1 | |
| SCHEMBL27303602 | 0.85 | FOLH1 (0.52) | FOLH1FFAR4CYP1A2FFAR1 | |
| SCHEMBL19079019 | 0.84 | FOLH1 (0.54) | FOLH1FFAR4RXRARXRBRXRG | |
| SCHEMBL25801389 | 0.83 | FOLH1 (0.52) | FOLH1FFAR4NPSR1FFAR1 | |
| SCHEMBL22131080 | 0.83 | FOLH1 (0.52) | FOLH1RXRACYP1A2CYP2C19PPARA | |
| SCHEMBL18811743 | 0.82 | FOLH1 (0.56) | FOLH1FFAR4 | |
| SCHEMBL18292001 | 0.82 | FOLH1 (0.54) | FOLH1FFAR4FFAR1 | |
| SCHEMBL29340370 | 0.82 | FOLH1 (0.51) | FOLH1FFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210322581-A1 | PHARMACEUTICAL FORMULATIONS | Blue Earth Diagnostics Limited (GB) | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210322581-A1 | PHARMACEUTICAL FORMULATIONS | SLC5A1, SLC5A11, SSTR3 | FOLH1 213/4885FFAR4 903/4885CYP2D6 2121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.